Dnata:企業のM&A・事業提携・投資動向

◆英語タイトル:Dnata - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1638
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:UAE
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Dnata – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Dnata Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Dnata since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Dnata’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Dnata. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Dnata’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Dnata and its subsidiaries since 2007.
- Information about key financial and legal advisors for Dnata’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Dnata’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 47
Partnership – Overview 47
Partnership – Deal reports 48
DIVESTMENTS 51
Divestments – Overview 51
Divestments – Deal reports 52
PRIVATE EQUITY & OWNERSHIP 54
Private Equity and Ownership – Deal reports 54
APPENDIX 56
Contact Us 56
About MarketLine Financial Deals Database 56
Deal Definition and Methodology 58
About MarketLine 65

List of Tables
Table 1: dnata M&A volume and value trend (2014-YTD2018)
Table 2: dnata M&A activity by geography (2014-YTD2018)
Table 3: dnata partnership volume and value trend (2014-YTD2018)
Table 4: dnata partnership trend by key deal type (2014-YTD2018)
Table 5: dnata divestments volume and value trend (2014-YTD2018)
Table 6: dnata divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: dnata M&A volume and value trend (2014-YTD2018)
Figure 2: dnata M&A activity by geography (2014-YTD2018)
Figure 3: dnata partnership volume and value trend (2014-YTD2018)
Figure 4: dnata partnership trend by key deal type (2014-YTD2018)
Figure 5: dnata divestments volume and value trend (2014-YTD2018)
Figure 6: dnata divestments by geography (2014-YTD2018)

★海外企業調査レポート[Dnata:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tanabe Research Laboratories USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Tanabe Research Laboratories USA Inc (TRL), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a healthcare research center that discovers biological drugs. The center conducts research on metabolics, inflammation and immunology. Its products are used for the therapy of serious diseases with …
  • GV Gold:企業の戦略・SWOT・財務情報
    GV Gold - Strategy, SWOT and Corporate Finance Report Summary GV Gold - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Celgene Corp (CELG):企業の財務・戦略的SWOT分析
    Celgene Corp (CELG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Screen Holdings Co Ltd (7735):企業の財務・戦略的SWOT分析
    Screen Holdings Co Ltd (7735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Vectren Corp (VVC):電力:M&Aディール及び事業提携情報
    Summary Vectren Corp (Vectren) is an energy holding company, which carries out the distribution and transmission of natural gas and electricity. Under its wholly owned subsidiary, Vectren Utility Holdings, Inc., the company operates three utilities; Vectren Energy Delivery of Indiana - North (Vectre …
  • Sanchez Midstream Partners LP (SPP):企業の財務・戦略的SWOT分析
    Summary Sanchez Midstream Partners LP (SMP), formerly Sanchez Production Partners LP, a subsidiary of Sanchez Oil & Gas Corp, is an oil and gas company that acquires, develops and operates midstream and other energy related assets. The company offers drilling results, production, and hedging service …
  • CryoLife Inc (CRY):医療機器:M&Aディール及び事業提携情報
    Summary CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company’s portfolio enlists preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide dif …
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Sensile Medical AG:医療機器:M&Aディール及び事業提携情報
    Summary Sensile Medical AG (Sensile) is a medical device company that develops and produces key technologies for liquid drug delivery devices. The company develops products in the areas of micro insulin delivery and glucose monitoring systems. Its pipeline products comprise sensepatch and senseflex. …
  • Bouygues SA (EN):電力:M&Aディール及び事業提携情報
    Summary Bouygues SA (Bouygues) is an industrial group which operates in construction, real estate development, media and telecommunication markets. It undertakes construction contracts for roads, airport runways, seaport, industrial infrastructure, parking areas, recreational facilities, electrical …
  • China Development Financial Holding Corporation:企業の戦略・SWOT・財務情報
    China Development Financial Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary China Development Financial Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • OSRAM Opto Semiconductors GmbH:企業の戦略的SWOT分析
    OSRAM Opto Semiconductors GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • HABAU Hoch- und TiefbauGmbH:企業の戦略的SWOT分析
    HABAU Hoch- und TiefbauGmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Co-operative Group Ltd:企業のM&A・事業提携・投資動向
    Co-operative Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Co-operative Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Mitsui Fudosan Co Ltd (8801):企業の財務・戦略的SWOT分析
    Mitsui Fudosan Co Ltd (8801) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • BNY Mellon Wealth Management:企業の戦略・SWOT・財務情報
    BNY Mellon Wealth Management - Strategy, SWOT and Corporate Finance Report Summary BNY Mellon Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • eFFECTOR Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary eFFECTOR Therapeutics Inc (Effector) is a biopharmaceutical company that concentrates on new class of oncology drugs-selective translation regulators. The company works on the discovery and development of translation regulators as a new small molecule therapeutics that control gene expressio …
  • Sanofi (SAN):医療機器:M&Aディール及び事業提携情報
    Summary Sanofi is a healthcare company that researches, develops, manufactures and markets a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human vaccines for protect …
  • Albireo Pharma Inc (ALBO)-製薬・医療分野:企業M&A・提携分析
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., is a specialty biopharmaceutical company that focuses on the development and commercialization of innovative bile acid modulators for the treatment of orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and d …
  • SOCOMEC Group:企業の戦略的SWOT分析
    SOCOMEC Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆